SELLAS Life Sciences Group, Inc. (SLS) Earnings
|
Expand Research on SLS
| Next EPS Date | 11/18/26 | EPS Growth Rate | 0.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +16.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/26  |
Q326 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.05 | -$0.05 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 5/12/26 |
Q126 | -$0.05 | -$0.07 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 5/7/26 |
Q126 | N/A | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/26 |
Q425 | N/A | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/18/26 |
Q425 | N/A | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/17/26 |
Q425 | N/A | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/16/26 |
Q425 | N/A | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A |
